Pulmonx (LUNG) Return on Invested Capital (2021 - 2025)

Pulmonx (LUNG) has 5 years of Return on Invested Capital data on file, last reported at 0.05% in Q3 2025.

• On a quarterly basis, Return on Invested Capital rose 3.0% year-over-year to 0.05% in Q3 2025; TTM through Sep 2025 was 0.05%, a 3.0% increase from a year earlier, with the FY2024 full-year figure at 0.22%, up 34.0% from the prior year.
• Return on Invested Capital for Q3 2025 stood at 0.05%, roughly flat from 0.05% in the prior quarter.
• Over the last five years, Return on Invested Capital for LUNG reached as high as 0.05% in Q2 2025 and fell as low as 0.45% in Q4 2023.
• Historically, Return on Invested Capital has averaged 0.12% across 5 years, with a median of 0.08% in 2024.
• Across the five-year window, Return on Invested Capital sank 38 bps in 2023 and soared 38 bps in 2024, its largest moves.
• Year by year, Return on Invested Capital stood at 0.08% in 2021, then grew by 20 bps to 0.07% in 2022, then plunged by 570 bps to 0.45% in 2023, then soared by 84 bps to 0.07% in 2024, then gained by 28 bps to 0.05% in 2025.
• Per Business Quant data, the three most recent Return on Invested Capital figures were 0.05% in Q3 2025, 0.05% in Q2 2025, and 0.06% in Q1 2025.